abaloparatide

Radius shares slide after FDA delays decision on bone drug
BioPharma Dive
Fri, 03/10/17 - 09:03 pm
Radius Health
FDA
abaloparatide
osteoporosis
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Endpoints
Mon, 09/19/16 - 09:53 am
Amgen
romosozumab
Radius Health
abaloparatide
osteoporosis
Split the pot? Radius shows its osteoporosis cards in final blockbuster match with Amgen
Endpoints
Wed, 08/17/16 - 10:38 am
Amgen
Radius Health
osteoporosis
abaloparatide
romosozumab
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
FDA
Rayaldee
OPKO Health
Nuplazid
Acadia
abaloparatide
Radius Health
pegvaliase
Biomarin
ALD403
Alder Biopharmaceuticals
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
BioPharma Dive
Wed, 02/24/16 - 04:48 pm
romosozumab
Amgen
osteoporosis
clinical trials
Eli Lilly
Forteo
Radius Health
abaloparatide